Related Experiment Video
Updated: Aug 8, 2025
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.7K
Insulin hesitancy: A language-based model.
Sanjay Kalra1, Bharti Kalra2, Saptarshi Bhattacharya3
1Department of Endocrinology, Bharti Hospital, Karnal.
JPMA. the Journal of the Pakistan Medical Association
|February 26, 2023
Summary
Insulin hesitancy is proposed to describe patient reluctance to use insulin. A triage model using patient adverbs ("will not," "shall not," "cannot") helps assess and address this common diabetes management challenge.
Area of Science:
- Endocrinology
- Psychology
- Diabetes Management
Background:
- Psychological insulin resistance is a recognized barrier in diabetes care.
- Patient reluctance to initiate insulin therapy is a significant clinical issue.
- Effective strategies are needed to overcome patient apprehension regarding insulin use.
Purpose of the Study:
- To introduce and define the term 'insulin hesitancy'.
- To propose a novel triage model for assessing insulin hesitancy based on patient language.
- To provide a framework for healthcare professionals to address patient concerns about insulin therapy.
Main Methods:
- Conceptual framework development.
- Linguistic analysis of patient statements regarding insulin initiation.
- Triage model based on predominant adverbs used by patients: 'will not', 'shall not', 'cannot'.
Main Results:
- The term 'insulin hesitancy' is proposed to capture patient reluctance.
- A triage model categorizes hesitancy based on adverbial indicators.
- 'Cannot' suggests a need for problem-solving, 'will not' for motivational interviewing, and 'shall not' for deeper psychological exploration.
Conclusions:
- Insulin hesitancy is a distinct concept from psychological insulin resistance.
- The proposed triage model offers a practical approach for clinicians to tailor conversations.
- Understanding patient language is key to effectively managing insulin initiation and improving diabetes outcomes.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
68.9K
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
10.4K
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
1.4K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.4K
01:16Insulin: Dosing Regimen and Adverse Effects
223
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
223
01:05Insulin Secretory Vesicles
5.1K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.1K
01:27Insulin Formulations: Types and Delivery
245
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
245
01:25Insulin: Biosynthesis, Chemistry, and Preparation
455
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
455
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K